3D Printable and Electrically Conductive Hyaluronic Acid Hydrogel for Cardiac and Vascular Tissue Engineering Applications Authors: Britanny L. Stark, Jose L. Perez, Edgar A. Borrego, Wilson Poon, Sylvia L. Natividad-Diaz Published: 2026 ABSTRACT Cardiovascular disease (CVD) is the leading cause of death worldwide. After acute myocardial infarction (AMI), the adult human heart has very limited regenerative capacities, and the electrical propagation of the myocardium is severely disrupted, which makes the patient more susceptible to heart failure and death. Current pharmaceutical treatments do not address the loss of cardiomyocytes (CMs) or the disruption of electrical propagation in the heart. Tissue engineering provides a potential solution with electrically conductive hydrogels that are biocompatible to promote CM viability, lineage-specific function, and vascularization while helping reestablish the electrical propagation of native myocardium. Incorporating patient-specific CMs and automated, rapid 3D printing techniques will improve the clinical translation of these engineered tissues for the repair of damaged myocardium. To address these limitations, we developed a novel, electrically conductive, photocurable, and 3D-printable hydrogel composed of methacrylated hyaluronic acid (MeHA) conjugated with 3-thiopheneacetic acid (3TAA) in deionized water. This novel, multifunctional hydrogel significantly increased electrical conductivity compared to MeHA alone, although a decrease in average storage modulus was observed with the 3TAA conjugation. Biocompatibility assessment demonstrated sustained cardiac and vascular cell activity in both MeHA and MeHA 3TAA hydrogels. Notably, CMs derived from human-induced pluripotent stem cells (hiPSCs) retained the expression of the cardiac biomarker CTnT and maintained spontaneous beating within MeHA and MeHA 3TAA hydrogels. Introduction Cardiovascular disease (CVD) is the leading cause of death in the United States and worldwide. Moreover, according to the American Heart Association, acute myocardial infarction (AMI) is the major contributor to CVD mortality. AMI causes cell death of as much as 25% of the cardiomyocytes present in the left ventricle of the heart, and the adult human heart has a very limited regenerative capacity. Despite the considerable advances in the treatment of CVDs, such as surgical interventions, pharmaceutical treatments, and ventricular assist devices, the need to mitigate the loss of cardiac tissue remains a major challenge. For instance, a common treatment for advanced AMI, heart transplantation, poses risks such as a lack of donors and organ rejection by the immune system. Furthermore, current pharmacological approaches for CVD aim to reduce blood volume or increase cardiac contractile force to prevent a recurring AMI, but none of these interventions repair the loss of cardiomyocytes. ,, One of the currently proposed solutions is cardiogenic therapies to stimulate regeneration of cardiomyocytes; however, an ongoing challenge for these therapies involves limiting the growth pathways of noncardiomyocytes. , Another proposed solution is to use scaffold-free cell therapies that include injected stem cell-derived cardiomyocytes, but these can result in ventricular arrhythmias and teratomas postinjection. These are all technologies that are difficult to translate into a clinical setting. The use of biomaterials and tissue engineering can potentially solve these challenges. , This technology offers the potential to create functional cardiac constructs that can mimic native myocardium. These engineered tissues aim to restore normal heart function, thereby addressing the limitations of donor organ shortages and other complications associated with traditional therapies. Moreover, hydrogels have gained substantial recognition as biomaterials due to their tunable physicochemical properties, biocompatibility, and ability to provide structural and mechanical support for cells. Some studies show improved retention, survival, and engraftment of cardiomyocytes when using hydrogels as a scaffold. ,, These types of biomaterials, while very useful, still necessitate improvement due to their limited or negligible electrical conductivity. Following AMI, the heart’s remaining cardiomyocytes are uncoupled and isolated, which leads to the disruption of electrical signaling propagation within the heart. The introduction of nonconductive hydrogels into the heart through injection or transplantation does not address the issue of electrical uncoupling of functional cardiomyocytes. ,, Thus, integrating electrical conductivity into these biomaterials can ultimately improve the propagation of electrical signals in the heart while addressing the lack of cardiomyocytes after AMI. In the present study, a conductive biopolymer was developed for use in cardiovascular tissue-engineering applications (Figure a). Hyaluronic acid (HA) is a major component of the extracellular matrix (ECM) and plays a role in cellular maintenance and crosstalk. In tissue-engineering applications, hyaluronic acid is an established biomaterial due to its biocompatibility, hydrophilicity, and chemical versatility. , Adding a methacrylate group to HA allows the material to be UV cross-linkable for scaffold design and 3D printing, and the chemical process for the methacrylate addition has been well established in previous literature. ,, Overview of tissue engineering applications of MeHA 3TAA hydrogels. (a) MeHA polymer was conjugated with 3-thiopheneacetic acid (3TAA). (b) Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes were encapsulated within the modified MeHA hydrogel. (c) MeHA 3TAA hydrogel containing hiPSC-derived cardiomyocytes was processed in a 3D stereolithography (SLA) printer to form engineered human cardiac tissue. (d) Cross-linked MeHA 3TAA hydrogels were used as a basement membrane to conduct an endothelial sprouting assay. This study’s method of incorporating conductivity into the hydrogel was done by adding thiophene via esterification, a well-established chemical reaction that refluxes carboxylic acid and alcohol with the aid of a catalyst. Thiophene is a colorless heterocyclic compound that becomes charged when treated with an oxidizing agent via a process called doping. This compound has good chemical stability and electrical conductivity without making the material more rigid and brittle, which makes it ideal for this application. The development of a conductive HA hydrogel using thiophene represents a promising avenue for advancing the field of cardiac tissue engineering. Furthermore, the implementation of 3D printing technologies provides rapid prototyping, streamlined design processes, and manufacturing precision for hydrogels (Figure c). These remarkable attributes make 3D printing an ideal candidate for applications in tissue engineering, ,,, where a demand exists for patient-specific designs in personalized medicine treatments. In a notable milestone, Mirdamadi et al. demonstrated the ability to 3D print a full-sized adult human heart based on MRI scans, showcasing the potential of their Freeform Reversible Embedding of Suspended Hydrogels (FRESH) technology. Despite tremendous progress in the field of 3D printing, the choice of materials for this advanced manufacturing technique remains a challenge. For applications in tissue engineering, these biomaterials must possess a unique blend of qualities, encompassing bioresorbability, bioactivity, biocompatibility, and mechanical robustness. , In this study, a MeHA Thiophene composite was developed to create a 3D printable conductive biopolymer for cardiovascular tissue engineering applications. This biopolymer was utilized to encapsulate hiPSC-derived cardiomyocytes (Figure b), as well as to facilitate the formation of a 3D printed human cardiac tissue (Figure c). Encapsulation of hiPSC-derived cardiomyocytes and an endothelial cell sprouting assay were used to assess the MeHA 3TAA hydrogel’s biocompatibility (Figure b, d). By imparting electrical conductivity while preserving the desirable properties of HA-based hydrogels, this approach has the potential to significantly enhance the regenerative potential of cardiac constructs and contribute to the development of novel therapies for CVDs while supporting other endogenous cell types, such as endothelial cells. Materials and Methods Electrically Conductive Hydrogel Synthesis Methacrylated hyaluronic acid (MeHA) (Sigma, Cat. No. CC327-1) was modified by chemical conjugation with 3-thiopheneacetic acid (3TAA) (Sigma, Cat. No. 220639-10G) doped with pure iodine (Sigma, Cat. No. 207772–5G). Prior to hydrogel synthesis, 3TAA was doped with pure iodine to initiate electrical conductivity, similar to previous studies. ,, A total of 12 mg of 3TAA was dissolved in deionized (DI) water, along with 2 mg of pure iodine. This solution was mixed for a 24-h period. After doping, the 10 mL 3TAA/I2 solution was mixed with 100 mg of lyophilized (as-received) MeHA and 1 mg of 1,1′-carbonyldiimidazole (CDI) (Sigma) and reacted for 24 h with continuous mixing. Subsequently, the solution was filtered using an 8 kDa dialysis membrane (ThermoFisher) for another 24 h in DI water. The resulting solution was clear and could be UV-cross-linked with the photoinitiator lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) (Sigma, Cat. No. CC327-2). For hydrogel cross-linking, the LAP photoinitiator was added at a concentration of 20 μL per mL of MeHA solution, then exposed to UV light of 405 nm wavelength for 60 s. Additive Manufacturing with 3D MSLA Printing Procedure The Prusa SL1S Speed MSLA printer (Prusa Research) was used to demonstrate proof-of-concept hydrogel cross-linking and shape specification with stereolithography-based 3D printing. This printer has a high-resolution monochrome LCD screen that displays the layers onto the print bed and a UV LED panel that cures the resin at a 405 nm wavelength. Regarding 3D printing parameters for the MeHA 3TAA hydrogel, the CAD design was made using SolidWorks, and the slicing software used was the Prusa Slicer. All slicing was adjusted to a layer height of 0.01 μm and a layer curing time of 60 s. Characterization Methods NMR Chemical analysis of the MeHA 3TAA hydrogel was done with proton NMR for three different batches of the hydrogel (n = 3). The instrument used for this study was an Avance III HD NanoBay NMR spectrometer (Bruker-Spectrospin). This NMR instrument was equipped with a 400 MHz magnet and a 5 mm PA BBO probe. Sample preparation for all batches consisted of lyophilization at −80 °C for 3 days and subsequent resuspension in 99.8%-grade deuterium oxide (D2O) (Sigma). The solution was placed in 400 MHz, 5 mm diameter Wilmad NMR tubes (Sigma). All data obtained was analyzed using MNova NMR Software (Mestrelab Research). Zetasizer Electrophoretic Light Scattering System The Zetasizer Ultra Red system (Malvern Panalytical) was used for conductivity measurements of the samples in DI water, including 3TAAA, 3TAA/I2, MeHA, and MeHA 3TAA (n = 3) via the electrophoretic light scattering (ELS) measurement mode. Samples were compared with DI water alone as the control. Rheology Mechanical properties of the MeHA and MeHA 3TAA hydrogels were obtained with a SmartPave 92 Dynamic Shear Rheometer (Anton Paar). An amplitude sweep of the MeHA and MeHA 3TAA hydrogels was performed six times each to establish the linear viscoelastic range (LVER) of the material. The shear strain rate for the test was set to a range spanning from 0.1 to 10%. After the LVER of the materials was established, a frequency sweep was conducted to determine the complex modulus of the material. Using the amplitude sweep data, the shear strain set for the frequency sweep was 1%, and the frequency was set to 1.99 Hz. All samples were printed as circles of 1 mm thickness and 10 mm diameter. All samples were tested in triplicate (n = 3) hydrogel batches. Biocompatibility Analysis Angiogenesis Assay To assess cellular organization on this novel hydrogel, an angiogenesis assay was conducted using the HBEC-5i human brain endothelial cell line (CRL-3245). This cell line was cultured with complete EGM2 (Lonza, Cat. No. CC-3156) medium on tissue culture polystyrene plates at 37 °C in a humidified environment with 5% CO2. A 96-well plate was loaded with 100 μL of MeHA and MeHA 3TAA hydrogels, which were then cross-linked as described earlier. HBEC-5i cells were then seeded at 62,500 cells per cm2 on the top surface of the hydrogels and placed in standard incubation conditions for 3 days. Images of the same position were captured at 2, 4, and 24 h after seeding. Immunofluorescence Microscopy Immunofluorescence staining and microscopy were performed on human-induced Pluripotent Stem Cells (hiPSC) (GM25267, Coriell Institute) that were differentiated into cardiomyocytes. Supplementary Figure 1 demonstrates the efficiency of hiPSC differentiation into cardiomyocytes within our study. The hiPSC-derived cardiomyocytes were encapsulated within the MeHA and MeHA 3TAA with a seeding density of 3 × 106 cells/mL and cultured for a period of 7 and 14 days in RPMI B27 complete media. Additionally, the hiPSC-derived cardiomyocytes were encapsulated in 3D-printed MeHA 3TAA and cultured for 5 days at a seeding density of 3 × 106 cells/mL in RPMI B27 complete media. Cells were cultured in Transwell inserts (Falcon, Cat. No. 08-771-10) placed within a 12-well plate for both MeHA and MeHA 3TAA. After culturing for the determined time, samples were fixed with 4% paraformaldehyde (PFA) (ThermoFisher) for 10 min and washed twice with PBS (ThermoFisher). The hydrogels were then permeabilized with 0.1% Triton (ThermoFisher) for 2 min and washed twice with PBS. All subsequent fluorescence staining was done with a blocking buffer composed of 2% BSA in PBS. The samples were stained with primary Cardiac Troponin T monoclonal antibody (13-11) (Invitrogen, Cat. No. MA5-12960) overnight at 4 °C, then the samples were washed twice with PBS, and Goat anti-Mouse Superclonal Alexa Fluor488 secondary antibody (Invitrogen, Cat. No. A28175) was added for 2 h at room temperature and washed twice with PBS. Before imaging, samples were stained with F-actin phalloidin (ActiRed 555 ReadyProbes, Invitrogen, Cat. No. R37112) for F-actin visualization and DAPI (NucBlue Fixed Cell Stain ReadyProbes, Invitrogen, Cat. No. R37606). Samples containing HBEC-5i cells were fixed, permeabilized, and blocked as stated above 24 h after seeding. These samples were stained with F-actin phalloidin and DAPI. After staining, the hydrogels were imaged, and z-stacks were collected using a Leica Thunder 3D Imager (Leica Microsystems). All fluorescence images were processed with ImageJ FIJI, an open-source software. hiPSC Cardiomyocytes Beat Rate Videos of the spontaneously beating hiPSC-derived cardiomyocytes were taken by using a Leica Thunder 3D Imager with a DLS 9000GT camera at 100 fps. The beat rate of the hiPSC-derived cardiomyocytes encapsulated in the MeHA and MeHA 3TAA hydrogels was calculated by using the average displacement over time. This calculation was made by using MTrackJ from ImageJ (NIH). From the average displacement, the beats per minute (bpm) were calculated based on the peaks of the displacement. Statistical Analysis All quantitative measurements were performed on triplicate samples, unless otherwise stated. All values are expressed as mean ± standard deviation (SD). One-way ANOVA with a posthoc Tukey test was used to compare three or more experimental groups, and *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001 was used to assess statistical significance using GraphPad Prism Software. The experiment groups were defined as deionized (DI) water (solvent and control), MeHA (untreated control), and MeHA 3TAA with or without iodine. Results and Discussion NMR Spectroscopy Demonstrates 3TAA Conjugation to MeHA The potential chemical conjugation of 3TAA to MeHA is shown in Figure (a) and was verified with proton NMR. Figure (b) shows the NMR spectra of MeHA, which is comparable to well-established studies, and Figure (c) shows the MeHA 3TAA NMR spectra. In Figure (a), the peaks for the backbone of hyaluronic acid can be seen between 4 and 3 ppm (labeled 1). The peaks that appear between 6.5 and 5.5 ppm and between 2 and 2.5 ppm (labeled 2) show the methacrylate group in MeHA. NMR spectra. MeHA conjugation reaction with (a) 3TAA, (b) MeHA, and (c) MeHA 3TAA. Label 1 indicates the HyA backbone, 2 indicates the methacrylate groups, and 3 indicates the thiophene group. In Figure (b), the same peaks from the MeHA can be seen, but there are an additional four peaks present. These peaks occur between 7 and 7.5 ppm and at 9 ppm, and they belong to the protons present in 3-thiopheneacetic acid (3TAA). Furthermore, the ratio of 3TAA to MeHA was calculated using an established method , and was determined to be approximately 3.61%. Supporting Information Figure 2 shows NMR data for replicate conjugation studies. ELS Data Shows Improved Conductivity The conductivity measurements taken with the ELS system show a significant increase in conductivity after doping the 3TAA with iodine. For a comprehensive overview, Table demonstrates the average conductivity measurements for 3TAA, doped 3TAA, and DI water as controls. 1Average ELS Conductivity Measurements CompoundConductivity (μS) (average ± SD)Coefficient of variation (%)DI water4.58 ± 2.3150.5I2 in DI water27.4 ± 5.6020.4Undoped 3TAA317.8 ± 3.691.2Doped 3TAA603.8 ± 37.06.13MeHA1333.7 ± 61.64.62MeHA 3TAA2499 ±119.84.80aAverage conductivity measurements for doped 3TAA and MeHA and MeHA 3TAA hydrogels. Average ELS Conductivity Measurements Average conductivity measurements for doped 3TAA and MeHA and MeHA 3TAA hydrogels. Similarly, the conductivity measurements for the MeHA conjugated with 3TAA demonstrated a significant increase in conductivity when compared to that of baseline MeHA. These data are summarized in Table , which shows the average conductivity measurements for MeHA and MeHA 3TAA. Figure (a) shows a statistical comparison of conductivity measurements among DI water, I2 in DI water, and two different concentrations of 3TAA in DI water. Similarly, Figure (b) shows a statistical comparison among DI water, MeHA, and MeHA 3TAA. These analyses demonstrate the improvement in conductivity achieved through the chemical conjugation of MeHA and 3TAA. Supporting Information Figure 3 shows representative ELS data for zeta potential analysis of MeHA conjugated with 3TAA in DI water. Conductivity measurements. The figure shows (a) conductivity for the doping of 3TAA and (b) conductivity for the MeHA 3TAA hydrogel using the Zetasizer ELS system (****p < 0.0001). 3D Printing of MeHA 3TAA Using Prusa SL1S Printer Illustrated in Figure is the 3D printing procedure of the MeHA 3TAA hydrogel. In the depiction presented in Figure (a), the step-by-step progression can be seen, showcasing the process of removing the hydrogel from the print bed after being printed. This pictogram shows the hydrogel in its solidified state through the stages of postprint operation. 3D SLA printing process. Pictogram showing the postprint process (a) of the 3D-printed MeHA 3TAA hydrogel (b). Furthermore, Figure (b) shows the outcome of the 3D printing process by displaying the printed hydrogel. Notably, these images demonstrate the hydrogel’s ability to be fabricated with additive manufacturing (layer deposition) and to retain a specific shape (rectangle in this case). The printed hydrogel shows the precision and fidelity achieved in translating the hydrogel fabrication into a 3D SLA-printable biomaterial. Mechanical Properties after 3TAA Conjugation Frequency sweep data show that the conjugated MeHA 3TAA has a significantly lower complex modulus compared with that of the MeHA. Table shows the average storage and loss moduli for both hydrogels. Figure (a,b) shows representative amplitude sweeps for MeHA and MeHA 3TAA hydrogels. Figure (c) shows a comparison between storage and loss modulus data, with a statistically significant difference between the two types of hydrogels. 2Rheological Data HydrogelMeasurement (Pa) (average ± SD)Coefficient of variation (%)MeHA storage modulus34.9 ± 2.5610.2MeHA 3TAA storage modulus26.7 ± 6.925.9MeHA loss modulus9.03 ± 0.636.70MeHA 3TAA loss modulus14.7 ± 3.423.1MeHA loss tangent0.23 ± 0.014.35MeHA 3TAA loss tangent0.54 ± 0.011.85aAverage storage modulus, loss modulus, and loss tangent for MeHA and MeHA 3TAA. Rheological Data Average storage modulus, loss modulus, and loss tangent for MeHA and MeHA 3TAA. Mechanical properties analysis. Representative amplitude sweeps for (a) MeHA and (b) MeHA 3TAA hydrogels. Statistical comparison in (c) storage and loss modulus and (d) loss tangent between MeHA and MeHA 3TAA (****p < 0.0001). Furthermore, the loss tangents between both hydrogels are significantly different (Figure (d)). The MeHA 3TAA hydrogel shows a higher loss tangent compared with MeHA, and loss tangent is the ratio of energy lost to energy stored during cyclic deformation. This indicates that MeHA 3TAA is a less rigid biomaterial compared to the MeHA hydrogel. These results demonstrate the potential for this biomaterial to be used as a 3D-printable, electrically conductive scaffold in cardiovascular tissue engineering applications. , MeHA 3TAA Hydrogel Retains Biocompatibility and Supports Vascular Endothelial Cell and Cardiomyocyte Functional Activity The angiogenesis sprouting assay (Figure (a)) demonstrated the ability of MeHA 3TAA to support vascular endothelial cells similar to that of the unmodified MeHA hydrogel. Cellular reorganization could be observed as soon as 4 h after seeding on both hydrogels. The endothelial cells continued to reorganize over time, with distinguishable sprouting clusters forming 24 h postseeding on the MeHA and MeHA 3TAA hydrogels. Biocompatibility and cell morphology characterization with MeHA and MeHA 3TAA hydrogels. (a) Angiogenesis Sprouting Assay of HBEC-5i cells seeded on MeHA and MeHA 3TAA hydrogels. Images captured at the same position are shown for 4 and 24 h postseeding for HBEC-5i cells on MeHA hydrogels and MeHA 3TAA hydrogels. Fluorescence microscopy images show HBEC-5i stained for F-actin (red) and DAPI (blue). (b) Immunostaining of hiPSC-derived cardiomyocytes shows immunostaining of hiPSC-derived cardiomyocytes encapsulated in MeHA and MeHA 3TAA and cultured for 7 and 14 days. The last column shows the hiPSC-derived cardiomyocyte cells encapsulated in 3D-printed MeHA 3TAA and cultured for 5 days. The human-induced pluripotent stem cell (hiPSC)-derived cardiomyocyte (Supporting Information Figure 1) demonstrated similar organization and morphology when encapsulated in the MeHA and MeHA 3TAA hydrogels in 3D fluorescence z-stack images (Figure (b)). In Figure (b), immunostaining of 3D-printed MeHA 3TAA hydrogels with hiPSC cardiomyocytes after 5 days in culture shows maintenance of cell morphology and lineage-specific biomarker expression, which is comparable with several other studies. − The average displacement calculated for the contractile movement of the cardiomyocytes was approximately 24 μm (±4.36) for MeHA 3TAA and approximately 4 μm (±2.75) for MeHA. The beat rate was determined using average displacement calculations based on previous studies. ,, The average beat per minute was calculated to be 80 bpm (±1.58) for the MeHA 3TAA hydrogel and 70 bpm (±1.47) for the MeHA hydrogel. Supplementary Movies 1 and 2 show the encapsulated hiPSC cardiomyocytes beating in MeHA and MeHA 3TAA hydrogels, respectively. Conclusions and Discussion This study demonstrated the development, characterization, and proof-of-concept evaluation of a novel, electrically conductive MeHA 3TAA hydrogel with potential to be used in cardiac tissue engineering applications for AMI, a condition that disrupts the electrical signaling system of the heart, which leads to arrhythmias, ventricular dysfunction, and, ultimately, heart failure. The nonconductive fibrotic scar tissue that arises after an AMI creates a barrier against normal electrical propagation in the heart, leaving viable cardiomyocytes in a state of electrical uncoupling and dysfunction. Because of this, the need for a conductive biopolymer emerged as a therapeutic tool to resolve the electrical impedance of fibrotic scar tissue in the native myocardium. Within this study, we demonstrated the development of a novel, electrically conductive, and 3D-printable hydrogel composed of thiophene conjugated to photocurable methacrylated hyaluronic acid (MeHA). Thiophene has been shown to be chemically stable, biocompatible, and an excellent conductor, while MeHA is a chemically versatile, hydrophilic, and biocompatible hydrogel that is ideal for this application. Within this study, we present a simple, straightforward chemical conjugation process to combine the photocurable MeHA hydrogel with 3-thiopheneacetic acid (3TAA) to create a unique biomaterial and supporting characterization data to demonstrate its electrical conductivity, mechanical properties, and biocompatibility with cardiac and endothelial cells for potential use in cardiovascular tissue engineering applications. Additionally, we demonstrate that the MeHA 3TAA hydrogel can be processed with 3D stereolithography printing and retain its specific printed dimensions and biocompatibility. This study demonstrates the proof-of-concept data for the development of a novel, electrically conductive, photocurable, and biocompatible hyaluronic acid–based hydrogel, which has significant potential to impact the field of cardiac tissue engineering by including electrophysiology properties within in vitro models such as tissue-on-a-chip or in vivo tissue regeneration approaches. The demonstrated biocompatibility with cardiomyocytes derived from human-induced pluripotent stem cells also shows the biomaterial’s application in personalized medicine applications. Many studies have shown that conductive biomaterials hold great potential in enhancing cardiac function after implantation. , However, much remains to be improved in terms of the conductive properties of the material and clinical translation. ,,,, Furthermore, several studies have indicated that materials exhibiting electrical conductivity outperform their counterparts, demonstrating enhanced adhesion, alignment, organization, and maturation of cardiomyocytes. ,, Future work for this hydrogel system will include optimization studies to conjugate RGD-based cell adhesion peptides to facilitate the construction of a complete engineered heart tissue. Additionally, hemocompatibility tests in accordance with regulatory guidelines and standards will be necessary for preclinical in vivo studies and clinical translation. Supplementary Material